AXQ Capital LP Has $586,000 Holdings in DaVita Inc. (NYSE:DVA)

AXQ Capital LP cut its stake in DaVita Inc. (NYSE:DVA - Free Report) by 42.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,921 shares of the company's stock after selling 2,941 shares during the period. AXQ Capital LP's holdings in DaVita were worth $586,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. SBI Securities Co. Ltd. bought a new position in DaVita during the 4th quarter worth approximately $41,000. Quarry LP acquired a new stake in shares of DaVita during the 3rd quarter valued at approximately $60,000. Venturi Wealth Management LLC boosted its holdings in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc boosted its holdings in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. increased its stake in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Trading Up 0.9 %

DVA traded up $1.36 during mid-day trading on Thursday, reaching $152.73. The stock had a trading volume of 410,680 shares, compared to its average volume of 783,449. The firm's fifty day simple moving average is $157.96 and its two-hundred day simple moving average is $157.53. The stock has a market capitalization of $12.22 billion, a P/E ratio of 14.22, a P/E/G ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on DVA shares. Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. StockNews.com lowered DaVita from a "buy" rating to a "hold" rating in a report on Friday, March 21st. Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.